Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Early Diagnosis of Alzheimer’s Disease -

Early Diagnosis of Alzheimer’s Disease

Buch | Hardcover
359 Seiten
2000
Humana Press Inc. (Verlag)
978-0-89603-452-5 (ISBN)
CHF 299,55 inkl. MwSt
Presents a survey of the research on early diagnostic markers for Alzheimer's disease, including the elucidation of changes in the brain revealed by structural and functional neuroimaging, as well as the characteristic patterns of cognitive decline that are documented by neuropsychological tests, various genetic markers, and biological assays.
Drs. Leonard Scinto and Kirk Daffner provide a comprehensive survey of new diagnostic approaches to Alzheimer's disease. The authoritative contributors critically survey the most promising current research on early diagnostic markers for Alzheimer's disease, including the elucidation of changes in the brain revealed by structural and functional neuroimaging, as well as the characteristic patterns of cognitive decline that are documented by sensitive neuropsychological tests, various genetic markers, and biological assays. Early Diagnosis of Alzheimer's Disease illuminates the complex issues surrounding the search for early markers of this increasingly widespread disease. It will establish a new standard reference guide for all those working with Alzheimer's patients.

1 Early Diagnosis of Alzheimer’s Disease: An Introduction.- 2 Current Approaches to the Clinical Diagnosis of Alzheimer’s Disease.- 3 Pathological Diagnosis of Alzheimer’s Disease.- 4 The Pathophysiology of Alzheimer’s Disease.- 5 Genetic Testing in the Early Diagnosis of Alzheimer’s Disease.- 6 Structural Imaging Approaches to Alzheimer’s Disease.- 7 Functional Imaging in Alzheimer’s Disease.- 8 Neuropsychological Detection of Early Probable Alzheimer’s Disease.- 9 Peripheral Markers of Alzheimer’s Disease: Directions from the Alzheimer Pathogenic Pathway.- 10 Pupillary Response as a Possible Early Biological Marker for Alzheimer’s Disease.- 11 Implications of Early Diagnosis for the Development of Therapeutics for Alzheimer’s Disease.- 12 An Ethical Context for Presymptomatic Testing in Alzheimer’s Disease.

Erscheint lt. Verlag 9.2.2000
Reihe/Serie Current Clinical Neurology
Zusatzinfo XIII, 359 p.
Verlagsort Totowa, NJ
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Laboratoriumsmedizin
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Studium 2. Studienabschnitt (Klinik) Anamnese / Körperliche Untersuchung
ISBN-10 0-89603-452-6 / 0896034526
ISBN-13 978-0-89603-452-5 / 9780896034525
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
aus Klinik und Praxis

von Torben Pottgießer; Stefanie Ophoven; Elisabeth Schorb

Buch | Softcover (2023)
Urban & Fischer (Verlag)
CHF 58,75
Neurographie, Myographie, Evozierte Potenziale und EEG

von Volker Milnik

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 79,95